Lannett Co Inc

6.14-0.1700-2.69%Vol 187.25K1Y Perf -7.65%
Aug 11th, 2020 15:27 DELAYED
BID6.14 ASK6.15
Open6.39 Previous Close6.31
Pre-Market6.17 After-Market6.31
 -0.14 -2.22%  - -%
Target Price
10.50 
Analyst Rating
Hold 3.00
Potential %
70.73 
Finscreener Ranking
     39.74
Insiders Trans % 3/6/12 mo.
-33/-33/- 
Value Ranking
     41.83
Insiders Value % 3/6/12 mo.
-91/-91/-46 
Growth Ranking
     38.73
Insiders Shares Cnt. % 3/6/12 mo.
-91/-91/-50 
Income Ranking
 —    -
Market Cap247.76M 
Earnings Rating
Buy
Price Range Ratio 52W %
11.76 
Earnings Date
25th Aug 2020

Today's Price Range

6.116.41

52W Range

4.8915.52

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
1.28%
1 Month
9.93%
3 Months
-13.80%
6 Months
-28.30%
1 Year
-7.65%
3 Years
-61.52%
5 Years
-88.26%
10 Years
44.06%

TickerPriceChg.Chg.%
LCI6.14-0.1700-2.69
AAPL440.73-10.1800-2.26
GOOG1 493.81-2.2900-0.15
MSFT205.24-3.0100-1.45
XOM45.190.68001.53
WFC25.380.68002.75
JNJ147.07-0.9600-0.65
FB259.08-3.9200-1.49
GE6.740.07001.05
JPM104.674.03004.00
Financial StrengthValueIndustryS&P 500US Markets
1.30
2.00
0.66
2.27
0.50
Leverage Ratio 3.70
ProfitabilityValueIndustryS&P 500US Markets
32.30
6.20
16.30
-17.40
-5.80
RevenueValueIndustryS&P 500US Markets
407.82M
10.11
-9.64
3.86
Earnings HistoryEstimateReportedSurprise %
Q03 20200.260.273.85
Q02 20200.270.270.00
Q01 20200.200.2210.00
Q04 20190.210.3776.19
Q03 20190.620.689.68
Q02 20190.680.8626.47
Q01 20190.400.4410.00
Q04 20180.640.640.00
Earnings Per EndEstimateRevision %Trend
6/2020 QR0.270.00-
6/2020 QR0.36-2.70Negative
6/2020 FY1.040.00-
6/2021 FY1.08-8.47Negative
Next Report Date25th Aug 2020
Estimated EPS Next Report0.27
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume187.25K
Shares Outstanding40.35M
Trades Count2.34K
Dollar Volume1.20M
Avg. Volume720.48K
Avg. Weekly Volume314.11K
Avg. Monthly Volume816.25K
Avg. Quarterly Volume665.39K

Lannett Co Inc (NYSE: LCI) stock closed at 6.23 per share at the end of the most recent trading day (a 1.28% change compared to the prior day closing price) with a volume of 482.43K shares and market capitalization of 247.76M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 1020 people. Lannett Co Inc CEO is Timothy C. Crew.

The one-year performance of Lannett Co Inc stock is -7.65%, while year-to-date (YTD) performance is -28.46%. LCI stock has a five-year performance of -88.26%. Its 52-week range is between 4.89 and 15.52, which gives LCI stock a 52-week price range ratio of 11.76%

Lannett Co Inc currently has a PE ratio of 101.80, a price-to-book (PB) ratio of 0.81, a price-to-sale (PS) ratio of 0.62, a price to cashflow ratio of 5.30, a PEG ratio of 2.32, a ROA of -2.64%, a ROC of 2.51% and a ROE of -9.71%. The company’s profit margin is -5.80%, its EBITDA margin is 16.30%, and its revenue ttm is $407.82 Million , which makes it $10.11 revenue per share.

Of the last four earnings reports from Lannett Co Inc, there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.27 for the next earnings report. Lannett Co Inc’s next earnings report date is 25th Aug 2020.

The consensus rating of Wall Street analysts for Lannett Co Inc is Hold (3), with a target price of $10.5, which is +70.73% compared to the current price. The earnings rating for Lannett Co Inc stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Lannett Co Inc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Lannett Co Inc has a Neutral technical analysis rating based on Technical Indicators (ADX : 10.60, ATR14 : 0.36, CCI20 : 113.98, Chaikin Money Flow : -0.08, MACD : -0.10, Money Flow Index : 55.76, ROC : 9.49, RSI : 50.63, STOCH (14,3) : 73.12, STOCH RSI : 0.84, UO : 49.01, Williams %R : -26.88), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Lannett Co Inc in the last 12-months were: Albert Paonessa (Sold 27 777 shares of value $322 380 ), David Drabik (Sold 37 220 shares of value $274 311 ), Patrick G. LePore (Buy at a value of $245 500), Paul Taveira (Sold 30 000 shares of value $216 600 ), Timothy C. Crew (Buy at a value of $57 590)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingHold
3.00
Hold
3.00
Hold
3.00

Lannett Co Inc

Lannett Co Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products. It offers solid oral, extended-release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. In addition, the company also provides its products for various medical indications comprising glaucoma, gastrointestinal, migraine, obesity, respiratory and others. It operates in the segment of generic pharmaceuticals. Its customers include generic pharmaceutical distributors, drug wholesalers, chain drug stores, private label distributors, mail-order pharmacies, and others.

CEO: Timothy C. Crew

Teplephone: +1 215 333-9000

Address: 9000 State Road, Philadelphia 19136, PA, USA

Number of employees: 1 020

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

65%35%

News

Stocktwits